Antimicrobial Peptide Conjugates Overcome Resistant Bacteria but Face Major Translational Obstacles
A review of antimicrobial peptide–drug conjugates through July 2026 shows marked activity against resistant pathogens alongside critical gaps in pharmacokinetic, ...

